Shorter Remission Telomere Length Predicts Delayed Neutrophil Recovery After Acute Myeloid Leukemia Therapy: A Report From the Children’s Oncology Group

PURPOSE: Suboptimal outcomes for children with acute myeloid leukemia (AML) necessitate maximally intensive therapy. Consequently, serious adverse events, such as prolonged periods of profound myelosuppression, contribute to AML treatment–related mortality. Telomeres, the repetitive DNA–protein stru...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Oncol
Main Authors: Gerbing, Robert B., Alonzo, Todd A., Sung, Lillian, Gamis, Alan S., Meshinchi, Soheil, Plon, Sharon E., Bertuch, Alison A., Gramatges, Maria M.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2016
Assuntos:
ORIGINAL REPORTS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5446304/
https://ncbi.nlm.nih.gov/pubmed/27354474
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2016.66.9622
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados